amphetamine has been researched along with Ambulation Disorders, Neurologic in 4 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As a test of plausibility for the hypothesis that schizophrenia can result from abnormal brain, especially cerebral cortical, development, these studies examined whether, in the rat, disruption of brain development initiated on embryonic day (E) 17, using the methylating agent methylazoxymethanol acetate (MAM), leads to a schizophrenia-relevant pattern of neural and behavioral pathology." | 7.73 | A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. ( Geyer, MA; Ghajarnia, M; Grace, AA; Jentsch, JD; Moore, H, 2006) |
| "As a test of plausibility for the hypothesis that schizophrenia can result from abnormal brain, especially cerebral cortical, development, these studies examined whether, in the rat, disruption of brain development initiated on embryonic day (E) 17, using the methylating agent methylazoxymethanol acetate (MAM), leads to a schizophrenia-relevant pattern of neural and behavioral pathology." | 3.73 | A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. ( Geyer, MA; Ghajarnia, M; Grace, AA; Jentsch, JD; Moore, H, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loiodice, S | 1 |
| Wing Young, H | 1 |
| Rion, B | 1 |
| Méot, B | 1 |
| Montagne, P | 1 |
| Denibaud, AS | 1 |
| Viel, R | 1 |
| Drieu La Rochelle, C | 1 |
| Cáceda, R | 1 |
| Binder, EB | 1 |
| Kinkead, B | 1 |
| Nemeroff, CB | 1 |
| Moore, H | 1 |
| Jentsch, JD | 1 |
| Ghajarnia, M | 1 |
| Geyer, MA | 1 |
| Grace, AA | 1 |
| Kelly, MP | 1 |
| Isiegas, C | 1 |
| Cheung, YF | 1 |
| Tokarczyk, J | 1 |
| Yang, X | 1 |
| Esposito, MF | 1 |
| Rapoport, DA | 1 |
| Fabian, SA | 1 |
| Siegel, SJ | 1 |
| Wand, G | 1 |
| Houslay, MD | 1 |
| Kanes, SJ | 1 |
| Abel, T | 1 |
4 other studies available for amphetamine and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.
Topics: Amphetamine; Animals; Antiparkinson Agents; Anxiety; Benserazide; Disease Models, Animal; Dopamine; | 2019 |
The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Topics: Acoustic Stimulation; Adamantane; Amphetamine; Analysis of Variance; Animals; Apomorphine; Behavior, | 2012 |
A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Brain; Central Nervous System Stimulan | 2006 |
Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.
Topics: Acoustic Stimulation; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; | 2007 |